Vaccines

Follow analytical innovations driving vaccine development and quality.

Diagram of lipid nanoparticles for mRNA vaccine delivery
ArticlesAs RNA therapeutics rapidly expand, ensuring the stability and efficacy of lipid nanoparticle (LNP) delivery systems requires advanced LC-MS strategies to accurately quantify complex lipid mixtures and identify critical degradation products.
ArticlesFirst described in the late 1980s, slalom chromatography returns. Fabrice Gritti explains the physics, engineering, and genomic QC breakthroughs behind the new GTxResolve Slalom column.
ArticlesAs saRNA therapeutics progress through clinical development and regulatory approval, advanced chromatography, CE, and LC-MS are empowering scientists to characterize, purify, and release increasingly large and complex nucleic acid molecules.
VideoNeil Kelleher discusses how greater mass spectrometry sensitivity could accelerate top-down proteomics and expand access to disease-relevant protein targets.